Teleflex Incorporated (NYSE:TFX) Stock Position Lifted by Villere ST Denis J & Co. LLC

Villere ST Denis J & Co. LLC grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 9.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 149,276 shares of the medical technology company’s stock after buying an additional 12,296 shares during the period. Teleflex comprises 2.4% of Villere ST Denis J & Co. LLC’s portfolio, making the stock its 21st largest position. Villere ST Denis J & Co. LLC’s holdings in Teleflex were worth $26,568,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the company. V Square Quantitative Management LLC lifted its holdings in Teleflex by 11.7% during the 4th quarter. V Square Quantitative Management LLC now owns 1,881 shares of the medical technology company’s stock worth $335,000 after buying an additional 197 shares during the last quarter. Vontobel Holding Ltd. raised its position in shares of Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock worth $248,000 after purchasing an additional 250 shares during the period. Asset Management One Co. Ltd. raised its position in shares of Teleflex by 15.6% during the 4th quarter. Asset Management One Co. Ltd. now owns 19,233 shares of the medical technology company’s stock worth $3,453,000 after purchasing an additional 2,589 shares during the period. Thompson Investment Management Inc. raised its position in shares of Teleflex by 31.5% during the 4th quarter. Thompson Investment Management Inc. now owns 3,340 shares of the medical technology company’s stock worth $594,000 after purchasing an additional 800 shares during the period. Finally, Entropy Technologies LP raised its position in shares of Teleflex by 20.9% during the 4th quarter. Entropy Technologies LP now owns 6,789 shares of the medical technology company’s stock worth $1,208,000 after purchasing an additional 1,173 shares during the period. Institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on TFX shares. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Truist Financial dropped their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Mizuho dropped their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Royal Bank of Canada lowered their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

Teleflex Stock Down 0.1 %

TFX opened at $167.44 on Friday. Teleflex Incorporated has a 12 month low of $166.76 and a 12 month high of $256.85. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market cap of $7.78 billion, a P/E ratio of 33.29, a P/E/G ratio of 1.72 and a beta of 1.16. The stock’s 50 day moving average price is $178.49 and its 200 day moving average price is $209.78.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.